The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4304-4312

  Katzif, Samuel ^a   Danavall, Damien ^a   Bowers, Samera ^a   Balthazar, Jacqueline T ^a,b   Shafer, William M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CATHEPSIN G [117-136]; CSPA PROTEIN; CSPB PROTEIN; DNA FRAGMENT; GENE PRODUCT; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIUM MUTANT; COLD STRESS; CSPA GENE; ESCHERICHIA COLI; GENE DELETION; GENE INSERTION; GENE LIBRARY; GENE MAPPING; GENE MUTATION; MAJOR COLD SHOCK GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS ISP479; START CODON; TRANSLATION INITIATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CATHEPSINS; COLD; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PEPTIDE FRAGMENTS; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SERINE ENDOPEPTIDASES; SIGMA FACTOR; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC;

EID: 0042766499     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4304-4312.2003     Document Type: Article

References (45)

1. Augustin, J., and F. Götz. 1990. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol. Lett. 66:203-208.
2. Belaaouaj, A., K. S. Kim, and S. D. Shapiro. 2000. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 289:1185-1188.
3. Bevins, C. L. 1994. Antimicrobial peptides as agents of mucosal immunity. CIBA Found. Symp. 186:250-269.
4. Boman, H. G. 1991. Antibacterial peptides: key components needed in immunity. Cell 65:205-207.
5. Brückner, R. 1997. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett. 151:1-8.
6. Devine, D. A., and R. E. W. Hancock. 2002. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des. 8:703-714.
7. Elsbach, P., and J. Weiss. 1988. Phagocytic cells: oxygen-independent systems, p. 445-470. In J. Gallin, I. M. Goldstein, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlations. Raven Press, New York, N.Y.
8. Francis, K. P., and G. S. A. B. Stewart. 1997. Detection and speciation of bacteria through PCR using universal major cold-shock protein primer oligomers. J. Ind. Microbiol. Biotechnol. 19:286-293.
9. Gallo, R. L., and K. M. Huttner. 1998. Antimicrobial peptides: an emerging concept in cutaneous biology. J. Investig. Dermatol. 111:739-743.
10. Ganz, T. 1999. Defensins and host defense. Science 286:420-421.
11. Graumann, P., K. S. Schroder, R. Schmid, and M. A. Maraheil. 1996. Cold-shock stress proteins in Bacillus subtilis. J. Bacteriol. 128:4611-4619.
12. Groisman, E. A. 1996. Bacterial responses to host-defense peptides. Trends Microbiol. 4:127-128.
13. Hancock, R. E. W., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
14. 2: a janus-faced proteinase with two opposite specificities. EMBO J. 15:5481-5491.
15. Horsburgh, M. J., J. L. Aish, I. J. White, L. Shaw, J. K. Lithgow, and S. J. Foster. 2002. Sigma B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J. Bacteriol. 184:5457-5467.
16. Janzon, L., and S. Arvidson. 1990. The role of the δ-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J. 9:1391-1399.
17. Kelley, K. J. 1996. Using host defenses to fight infectious diseases. Nat. Bio/Technot. 14:587-590.
18. Kreiswirth, B., S. Lofdahl, M. J. Betley, M. O'Reilly, M. P. Shlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 35:709-712.
19. Kullik, I., and P. Giachino. 1997. The alternative sigma factor sigma B in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock. Arch. Microbiol. 167:151-159.
20. B in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180:4814-4820.
21. Lorenz, U., K. Ohlsen, H. Karch, M. Hecker, A. Thiede, and J. Hacker. 2000. Human antibody response during sepsis against targets expressed by methicillin-resistant Staphylococcus aureus. FEMS. Immunol. Med. Microbiol. 29:145-153.
22. Mak, P., J. Pohl, A. Dubin, M. S. Reed, S. E. Bowers, M. T. Fallon, and W. M. Shafer. 2003. The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int. J. Antimicrob. Agents 21:13-19.
23. Ménard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
24. Miyasaki, K. T., and A. L. Bodeau. 1991. In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J. Clin. Investig. 87:1585-1593.
25. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457.
26. Novick, R. P. 1967. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
27. Odeberg, H., and I. Olsson. 1975. Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect. Immun. 14:1269-1275.
28. Odeberg, H., and I. Olsson. 1976. Antibacterial activity of cationic proteins from human granulocytes. J. Clin. Investig. 56:1118-1124.
29. Peschel, A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10:179-186.
30. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Götz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
31. Peschel, A., C. Vuong, M. Otto, and F. Götz. 2000. The D-alanine residues of Staphylococcus aureus teichoic acids after the susceptibility to vancomycin and the activity of autolysins. Antimicrob. Agents Chemother. 44:2845-2847.
32. Peschel, A., R. W. Jack, M. Otto, L. V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W. F. Nieuwenhuizen, G. Jung, A. Tarkowski, K. P. M. van Kellsl, and J. A. G. van Strijk. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193:1067-1076.
33. + flux. Nature 416:291-297.
34. Salvesen, G., D. Farley, J. Shuman, A. Przybla, C. Relley, and J. Travis. 1987. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26:2289-2293.
35. Sarkar, G., R. T. Turner, and M. E. Bolander. 1993. Restriction-site PCR: a direct method of unknown sequence retrieval adjacent to a known locus by using universal primers. PCR Methods Appl. 2:318-322.
36. Shafer, W. M., and J. J. landolo. 1979. Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus. Infect. Immun. 25:902-911.
37. Shafer, W. M., M. E. Shepherd, B. Boltin, L. Wells, and J. Pohl. 1993. Synthetic peptides of human lysosomal cathepsin G having potent antipseudomonal activity. Infect. Immun. 61:1900-1908.
38. Shafer, W. M., F. Hubalek, M. Huang, and J. Pohl. 1996. Bactericidal activity of a synthetic peptide (CG 117-136) of human cathepsin G is dependent on arginine content. Infect. Immun. 64:4842-4845.
39. Shafer, W. M., S. Katzif, S. Bowers, M. Fallon, M. Hubalek, M. S. Reed, P. Veprek, and J. Pohl. 2002. Tailoring an antibacterial peptide of human lysosomal cathepsin G to enhance its broad-spectrum action against antibiotic-resistant bacterial pathogens. Curr. Pharm. Des. 8:695-702.
40. Shafer, W. M., V. C. Onunka, and L. E. Martin. 1986. Antigonococcal activity of human neutrophil cathepsin G. Infect. Immun. 54:184-188.
41. Shafer, W. M., and V. C. Onunka. 1989. Mechanisms of staphylococcal resistance to non-oxidative antimicrobial action of human neutrophils: importance of pH and ionic strength in determining the bactericidal activity of cathepsin G. J. Gen. Microbiol. 135:825-830.
42. Spitznagel, J. K. 1990. Antibiotic proteins of human neutrophils. J. Clin. Investig. 86:1381-1386.
43. Weber, K. L., M. E. Bolander, and G. Sarkar. 1998. Rapid acquisition of unknown DNA sequence adjacent to a known segment by multiplex restriction site PCR. BioTechniques 25:415-419.
44. Yamanaka, K. 1999. Cold shock response in Escherichia coli. J. Mol. Microbiol. Biotechnol. 1:193-202.
45. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. J. Gene 33:103-119.